ADB-BUTINACA

ADB-BUTINACA (also known as ADMB-BINACA using EMCDDA naming standards ) is a synthetic cannabinoid compound which has been sold as a designer drug. It is a potent CB1 agonist, with a binding affinity of 0.29nM for CB1 and 0.91nM for CB2, and an EC50 of 6.36 nM for CB1.